A new FDA-approved drug brings in a lot of hope for men with aggressive prostate cancer, as it may increase their chances of survival by 40 per cent. According to experts, the combination of two drugs ...

The known prostate cancer drug, Abiraterone, will be accessible for patients in the coming week, after a campaign led by a ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

Treatment with Leuprorelin did not improve OS or disease-specific survival for patients with nonmetastatic, high-risk prostate cancer who have undetectable PSA levels, while causing more adverse ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate cancer. The international study, published in The New England Journal of ...

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...